{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T15:03:48Z","timestamp":1774364628195,"version":"3.50.1"},"reference-count":0,"publisher":"Oxford University Press (OUP)","issue":"14","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1999,7,15]]},"DOI":"10.1093\/ajhp\/56.14.1451","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T11:42:21Z","timestamp":1549021341000},"page":"1451-1454","source":"Crossref","is-referenced-by-count":14,"title":["Concerns with defining appropriate uses of albumin by meta-analysis"],"prefix":"10.1093","volume":"56","author":[{"given":"Brian L.","family":"Erstad","sequence":"first","affiliation":[{"name":"Department of Pharmacy Practice and Science, College of Pharmacy, University of Arizona, P.O. Box 210207, Tucson, AZ 85721-0207"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","container-title":["American Journal of Health-System Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ajhp\/article-pdf\/56\/14\/1451\/28458123\/ajhp1451.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T13:14:32Z","timestamp":1555420472000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajhp\/article\/56\/14\/1451\/5159347"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1999,7,15]]},"references-count":0,"journal-issue":{"issue":"14","published-print":{"date-parts":[[1999,7,15]]}},"URL":"https:\/\/doi.org\/10.1093\/ajhp\/56.14.1451","relation":{},"ISSN":["1079-2082","1535-2900"],"issn-type":[{"value":"1079-2082","type":"print"},{"value":"1535-2900","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1999,7,15]]},"published":{"date-parts":[[1999,7,15]]}}}